Last reviewed · How we verify

NCT05571800

Effect of Mango Consumption on Individuals with Pre-diabetes

Completed NA Last updated 20 November 2024
What this trial tests

NA trial testing Mango in PreDiabetes in 24 participants. Completed in 31 July 2024.

Timeline
1 May 2022
Primary endpoint
31 July 2024
31 July 2024

Quick facts

Lead sponsorFlorida State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment24
Start date1 May 2022
Primary completion31 July 2024
Estimated completion31 July 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Florida State University

Who can join

Adults 50 to 70, any sex, with PreDiabetes or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to explore the effect of mango consumption on glycemic indices, cardiovascular health, and body composition in overweight and obese individuals with prediabetes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Daily Mango Intake Improves Glycemic and Body Composition Outcomes in Adults with Prediabetes: A Randomized Controlled Study.
    Basiri R, Dawkins K, Singar S, Ormsbee LT, et al · · 2025 · cited 2× · PMID 40941087 · DOI 10.3390/foods14172971

Verify or expand the search:

Other trials of Mango

Trials testing the same drug.

Other recruiting trials for PreDiabetes

Currently open trials in the same condition.

Other Florida State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05571800.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing